Brook, M., Hester, J., Petchey, W., Rombach, I., Dutton, S., Bottomley, M., . . . Issa, F. (2022). Transplantation Without Overimmunosuppression (TWO) study protocol: A phase 2b randomised controlled single-centre trial of regulatory T cell therapy to facilitate immunosuppression reduction in living donor kidney transplant recipients. BMJ Publishing Group.
Chicago Style (17th ed.) CitationBrook, MO, et al. Transplantation Without Overimmunosuppression (TWO) Study Protocol: A Phase 2b Randomised Controlled Single-centre Trial of Regulatory T Cell Therapy to Facilitate Immunosuppression Reduction in Living Donor Kidney Transplant Recipients. BMJ Publishing Group, 2022.
ציטוט MLABrook, MO, et al. Transplantation Without Overimmunosuppression (TWO) Study Protocol: A Phase 2b Randomised Controlled Single-centre Trial of Regulatory T Cell Therapy to Facilitate Immunosuppression Reduction in Living Donor Kidney Transplant Recipients. BMJ Publishing Group, 2022.